1. Home
  2. NHS vs EARN Comparison

NHS vs EARN Comparison

Compare NHS & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NHS
  • EARN
  • Stock Information
  • Founded
  • NHS 2003
  • EARN 2012
  • Country
  • NHS United States
  • EARN United States
  • Employees
  • NHS N/A
  • EARN N/A
  • Industry
  • NHS Trusts Except Educational Religious and Charitable
  • EARN Real Estate Investment Trusts
  • Sector
  • NHS Finance
  • EARN Real Estate
  • Exchange
  • NHS Nasdaq
  • EARN Nasdaq
  • Market Cap
  • NHS 226.7M
  • EARN 189.7M
  • IPO Year
  • NHS N/A
  • EARN 2013
  • Fundamental
  • Price
  • NHS $7.15
  • EARN $5.35
  • Analyst Decision
  • NHS
  • EARN Buy
  • Analyst Count
  • NHS 0
  • EARN 2
  • Target Price
  • NHS N/A
  • EARN $5.88
  • AVG Volume (30 Days)
  • NHS 111.8K
  • EARN 343.0K
  • Earning Date
  • NHS 01-01-0001
  • EARN 11-19-2025
  • Dividend Yield
  • NHS 13.44%
  • EARN 18.15%
  • EPS Growth
  • NHS N/A
  • EARN N/A
  • EPS
  • NHS N/A
  • EARN N/A
  • Revenue
  • NHS N/A
  • EARN $35,893,000.00
  • Revenue This Year
  • NHS N/A
  • EARN N/A
  • Revenue Next Year
  • NHS N/A
  • EARN $15.93
  • P/E Ratio
  • NHS N/A
  • EARN N/A
  • Revenue Growth
  • NHS N/A
  • EARN 43.30
  • 52 Week Low
  • NHS $6.95
  • EARN $4.33
  • 52 Week High
  • NHS $9.17
  • EARN $6.99
  • Technical
  • Relative Strength Index (RSI)
  • NHS 38.70
  • EARN 56.59
  • Support Level
  • NHS $7.04
  • EARN $5.08
  • Resistance Level
  • NHS $7.27
  • EARN $5.24
  • Average True Range (ATR)
  • NHS 0.09
  • EARN 0.11
  • MACD
  • NHS -0.03
  • EARN 0.02
  • Stochastic Oscillator
  • NHS 25.88
  • EARN 91.37

About NHS Neuberger Berman High Yield Strategies Fund

Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

Share on Social Networks: